Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience

Recruiting Observational Study
Oral Lichen Planus Oral Carcinoma Oral Carcinoma in Situ
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Catholic University of the Sacred Heart · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective of this paper will be to evaluate the rate of malignant transformation among a cohort of patients affected by oral lichen planus with long-term follow-up. Secondary aims will be to study and describe the characteristics of these patients to identify potential risk factors for malignant transformation, and to evaluate the therapeutic effects and features to OLP drgus.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical-histological diagnosis of Oral lichen planus * Patients who gave consensus to personal data treatment * Minimum 6 months follow-up Exclusion Criteria: * Patients who did not give consensus to personal data treatment * Oral lichenoid lesions * Patients with anamnesis…
Contacts

Carlo Lajolo Associate Professor, DDS, MD, PhD

3356078354

carlo.lajolo@unicatt.it

CONTACT

Carlo Lajolo Associate Professor, MD, DDS, PhD

3356078354

carlo.lajolo@unicatt.it

CONTACT